Blog Posts
DPD Deficiency Test
aacr.org

DPD Deficiency Test and FDA Labeling: Current Landscape at FDA-AACR Workshop

American Association for Cancer Research (AACR) shared a post on X:

“DPD Deficiency Test and FDA Product Labeling: Current Landscape.

Michael Pacanowski, Robert Diasio, Victoria Pratt, Evan Bryson, Sam Abdelghany, D. Max Smith, and Jill Bates addressed this topic in a session at today’s U.S. FDA – AACR Workshop.”

DPD Deficiency Test and FDA Labeling: Current Landscape at FDA-AACR Workshop

More posts featuring AACR.

AACR American Association for Cancer Research cancer DPD Deficiency Test OncoDaily Oncology U.S. FDA U.S. FDA - AACR Workshop